View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

International Consolidated Airlines Group SA: 1 director

A director at International Consolidated Airlines Group SA sold 500,000 shares at 319p and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

Moody's Ratings affirms IAG's Baa3 ratings; changes outlook to positiv...

Moody's Ratings (Moody's) has today affirmed the Baa3 senior unsecured ratings and long-term issuer rating of International Consolidated Airlines Group, S.A. (IAG or the company) and changed the outlook to positive from stable. "The outlook change to positive on IAG reflects our view that the grou...

Deutsche Lufthansa AG: 1 director

A director at Deutsche Lufthansa AG bought 7,000 shares at 6.290EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Rafael Bonardell
  • Rafael Bonardell

IAG: 1Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

1Q'25 vs. 1Q'24 Results Sales: € 7.044 Bn; EBIT: € 198.0 M (+191.2% vs. +130.9% BS(e) and +95.6% consensus).

Rafael Bonardell
  • Rafael Bonardell

IAG: MENSAJES DE LA CONFERENCE CALL RDOS. 1T’25 (ANÁLISIS BANCO SABADE...

De la conference call de Rdos. 1T’25 destacamos:  Demanda: el management destaco la fortaleza de la demanda,

Ignacio Romero
  • Ignacio Romero

IAG: RDOS. 1T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 1T'25 vs 1T'24: Ventas: 7.044 M euros (n/a vs n/a BS(e) y n/a consenso); EBIT: 198,0 M euros (+191,2% vs +130,9% BS(e) y +95,6% consenso).

Carole Braudeau
  • Carole Braudeau

Credit Morning 05/02/2025

The acquisition of IFF Pharma Solutions has been completed|Ontex Q1 25 call notes: Not alarming yet|Biogroup released weak results in 2024|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 02/05/2025

L'acquisition d'IFF Pharma Solutions a été finalisée|Ontex Q1 25 call notes: Not alarming yet|Biogroup : les résultats se contractent en 2024|

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/30/2025

Flos B&B Italia: after strong Q4 results, the start of the year is proving much more difficult|ams OSRAM: Q1 2025 results ahead of expectations, strategic options considered for certain assets|Viridien: a good set of Q1 2025 results, and FY 2025 FCF guidance confirmed|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 30/04/2025

Flos B&B Italia : après de bons résultats T4, le début d’année est bien plus difficile|ams OSRAM : résultats au T1 2025 supérieurs au consensus, options stratégiques étudiées pour certains actifs|Viridien: a good set of Q1 2025 results, and FY 2025 FCF guidance confirmed|

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch